(secondQuint)Bioequivalence Study of Metformin HCl 750 mg XR Under Fasting Conditions.

 This study was randomised, two-treatment, two-period, two-sequence, single-dose, crossover bioavailability study planned on 60 healthy, adult, subjects under fasting conditions.

 60 subjects were enrolled and 55 subjects completed all the periods of the study.

 Both periods were separated by a washout period of fourteen days A total of Sixty (60) subjects were enrolled in this study; 55 completed the study.

.

 Bioequivalence Study of Metformin HCl 750 mg XR Under Fasting Conditions@highlight

The objective of this study is to compare the relative bioavailability of metformin HC1 750 mg extended-release tablets (Ranbaxy) with that of Glucophage(R) XR 750 mg tablets (Bristol Myers Squibb) in healthy, adult, subjects under fasting conditions.

